aTyr Pharma Inc. (LIFE)
NASDAQ: LIFE
· Real-Time Price · USD
1.90
0.05 (2.70%)
At close: Jun 04, 2024, 10:00 PM
aTyr Pharma Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -1.94 | -1.28 | -1.67 | -1.73 | -2.04 | -1.42 | -2.02 | -2.41 | -1.98 | -2.25 | -1.65 | -1.62 | -3.12 | -6.06 | -5.38 | -1.89 | -2.19 |
PEG Ratio | 0.06 | -0.04 | n/a | n/a | 0.25 | -0.06 | 0.22 | 0.13 | -0.16 | 0.05 | -0.73 | -0.7 | -0.08 | 0.23 | 0.16 | -0.07 | -0.26 |
PS Ratio | n/a | -24.68 | n/a | n/a | 537.08 | 19.36 | 259.09 | n/a | n/a | 6.14 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 1.54 | 1.65 | 1.76 | 1.38 | 1.49 | 0.92 | 0.93 | 1.12 | 0.80 | 0.89 | 1.12 | 0.92 | 1.51 | 1.90 | 1.40 | 1.92 | 1.27 |
P/FCF Ratio | n/a | 2.64 | -5.11 | n/a | -5.64 | -7.54 | -9.04 | -8.27 | -47.92 | -5.55 | -6.77 | -8.66 | -14.65 | -25.6 | -14.3 | -10.11 | -10.74 |
P/OCF Ratio | n/a | 2.68 | -5.11 | n/a | -5.64 | -7.55 | -9.57 | -9.92 | -149.13 | -6.15 | -7 | -8.71 | -14.71 | -25.66 | -14.38 | -10.23 | -10.77 |
OCF/S Ratio | n/a | -9.21 | n/a | n/a | -95.23 | -2.56 | -27.08 | n/a | n/a | -1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.17 | 0.19 | 0.21 | 0.17 | 0.17 | 0.17 | 0.15 | 0.14 | 0.13 | 0.16 | 0.11 | 0.01 | 0.01 | 0.01 | 0.01 | 0.04 | 0.04 |
Quick Ratio | 7.79 | 5.48 | 5.41 | 7.63 | 6.07 | 6.27 | 15.77 | 17.04 | 15.73 | 6.06 | 7.75 | 10.08 | 16.45 | 18.91 | 20.92 | 6.37 | 11.77 |
Current Ratio | 7.79 | 5.48 | 5.41 | 7.63 | 6.07 | 6.27 | 8.36 | 9.25 | 8.75 | 5.85 | 7.76 | 10.08 | 16.45 | 18.91 | 20.92 | 6.37 | 11.77 |
Asset Turnover | n/a | -0.05 | n/a | n/a | 0.00 | 0.04 | 0.00 | n/a | n/a | 0.11 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -0.2 | -0.32 | -0.26 | -0.2 | -0.18 | -0.16 | -0.12 | -0.12 | -0.1 | -0.1 | -0.17 | -0.14 | -0.12 | -0.08 | -0.07 | -0.25 | -0.14 |
Return on Assets | -0.15 | -0.23 | -0.19 | -0.15 | -0.14 | -0.12 | -0.09 | -0.09 | -0.08 | -0.07 | -0.14 | -0.13 | -0.11 | -0.07 | -0.06 | -0.21 | -0.13 |
Return on Invested Capital | -0.18 | -0.27 | -0.23 | -0.18 | -0.17 | -0.15 | -0.11 | -0.11 | -0.1 | -0.09 | -0.15 | -0.14 | -0.12 | -0.08 | -0.06 | -0.24 | -0.13 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | 0.59 | n/a | n/a | 0.28 | 0.91 | -1.81 | n/a | n/a | 0.93 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | 4.81 | n/a | n/a | -65.92 | -3.42 | -32.12 | n/a | n/a | -0.68 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | 4.81 | n/a | n/a | -65.9 | -3.42 | -32.12 | n/a | n/a | -0.72 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | 4.86 | n/a | n/a | -70.79 | -3.7 | -35.74 | n/a | n/a | -0.77 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | 4.81 | n/a | n/a | -67.51 | -3.6 | -35.74 | n/a | n/a | -0.77 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |